Clinical trials
Tuberculosis, Pulmonary trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 5 |
| 2011 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Unknown status | 14 |
| Recruiting | 4 |
| Withdrawn | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johns Hopkins University | 2 |
| Seoul National University Hospital | 2 |
| Tuberculosis Clinical Diagnostics Research Consortium | 2 |
| Universitas Padjadjaran | 2 |
| Aga Khan University | 1 |
| Allama Iqbal Open University Islamabad | 1 |
| Arba Minch University | 1 |
| Bahir Dar University | 1 |
| Beijing Chest Hospital | 1 |
| Canan Güngör | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis, Pulmonary | 60 |
| Tuberculosis | 26 |
| Acquired Immunodeficiency Syndrome | 4 |
| Disease | 4 |
| Latent Tuberculosis | 4 |
| Tuberculosis, Multidrug-Resistant | 3 |
| Bacterial Infections | 2 |
| HIV Infections | 2 |
| Mycobacterium Infections | 2 |
| Tuberculosis, Extrapulmonary | 2 |
Trials
Showing 26 to 50 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.